850368 | 20:0 PC

1,2-diarachidoyl-sn-glycero-3-phosphocholine


Powder

Size SKU Packaging Price
25mg 850368P-25mg 850368P-25mg 1 x 25mg $94.00
200mg 850368P-200mg 850368P-200mg 1 x 200mg $172.00
500mg 850368P-500mg 850368P-500mg 1 x 500mg $270.00

Chloroform

Size SKU Packaging Price
25mg 850368C-25mg 850368C-25mg 1 x 25mg 10mg/mL 2.5mL $94.00
Base Price: ${originalprice|money}
Custom Packaging: (${concentration} @$4.00/ea. + $100) ${custompackagingtotal|money}
Packaging: ${concentration}
Item Total: ${totalprice|money}
(Sales Tax may apply)
Please select an option above.
${sku} - ${concentration}

20:0 PC

20:0 PC

1,2-diarachidoyl-sn-glycero-3-phosphocholine

The list of Phosphatidylcholine products offered by Avanti is designed to provide compounds having a variety of physical properties. Products available include short chain (C3-C8 are water soluble and hygroscopic), saturated, multi-unsaturated and mixed acid PC's. All of the products are purified by HPLC, and special precautions are taken to protect the products from oxidization and hydrolysis. Several of these products are manufactured under the current guidelines of Good Manufacturing Practice and are available for pharmaceutical use. If you have a requirement for a choline derivative not found on our list, please call us: custom synthesis is one of our specialties.

Hygroscopic
No
Light Sensitive
No
Molecular Formula
C48H96NO8P
Percent Composition
C 68.13%, H 11.43%, N 1.66%, O 15.12%, P 3.66%
Purity
>99%
Stability
1 Years
Storage Temperature
-20°C
CAS Number
61596-53-0
CAS Registry Number is a Registered Trademark of the American Chemical Society
Formula Weight
846.252
Exact Mass
845.687
Synonyms
1,2-dieicosanoyl-sn-glycero-3-phosphocholine
PC(20:0/20:0)

Böckmann KA, von Stumpff A, Bernhard W, Shunova A, Minarski M, Frische B, Warmann S, Schleicher E, Poets CF, Franz AR. Fatty acid composition of adipose tissue at term indicates deficiency of arachidonic and docosahexaenoic acid and excessive linoleic acid supply in preterm infants. Eur J Nutr. 2020 May 31. doi: 10.1007/s00394-020-02293-2. Epub ahead of print. PMID: 32476053.

PubMed ID: 32476053

Betker JL, Anchordoquy TJ. The Use of Lactose as an Alternative Coating for Nanoparticles. J Pharm Sci. 2020 Jan 28:S0022-3549(20)30026-5. doi: 10.1016/j.xphs.2020.01.019. Epub ahead of print. PMID: 32004536.

PubMed ID: 32004536

Mücksch F, Citir M, Lüchtenborg C, Glass B, Traynor-Kaplan A, Schultz C, Brügger B, Kräusslich HG. Quantification of phosphoinositides reveals strong enrichment of PIP2 in HIV-1 compared to producer cell membranes. Sci Rep. 2019 Nov 27;9(1):17661. doi: 10.1038/s41598-019-53939-z.

PubMed ID: 31776383

Morito K, Shimizu R, Kitamura N, Park SB, Kishino S, Ogawa J, Fukuta T, Kogure K, Tanaka T. Gut microbial metabolites of linoleic acid are metabolized by accelerated peroxisomal β-oxidation in mammalian cells. Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jul 24;1864(11):1619-1628. doi: 10.1016/j.bbalip.2019.07.010. [Epub ahead of print]

PubMed ID: 31351225

Palchetti S, Caputo D, Digiacomo L, Capriotti AL, Coppola R, Pozzi D, Caracciolo G. Protein Corona Fingerprints of Liposomes: New Opportunities for Targeted Drug Delivery and Early Detection in Pancreatic Cancer. Pharmaceutics. 2019 Jan 15;11(1). pii: E31. doi: 10.3390/pharmaceutics11010031.

PubMed ID: 30650541

Matthew G Fete, Jamie L Betker, Richard K Shoemaker, and Thomas J Anchordoquy. A novel method for conjugating the terminal amine of peptide ligands to cholesterol: synthesis iRGD-cholesterol. Therapeutic Delivery Vol. 10, No. 1. 2018 Dec 7. doi: 10.4155/tde-2018-0057